Impact of serum basic fibroblast growth factor on prognosis in human renal cell carcinoma

European Journal of Cancer

Volumn 37, Issue 17, 2001, Pages 2199-2203

  Rasmuson, T ^a   Grankvist, K ^a   Jacobsen, J ^a   Ljungberg, B ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

Angiogenic factor; Basic fibroblast growth factor; Nuclear grade; Prognosis; Renal cell carcinoma; Stability; Stage

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; INTERFERON; MEDROXYPROGESTERONE ACETATE;

ADULT; AGED; ARTERY OCCLUSION; ARTICLE; CANCER GRADING; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; FOLLOW UP; HUMAN; INFERIOR CAVA VEIN; KIDNEY CARCINOMA; KIDNEY VEIN; MAJOR CLINICAL STUDY; MALE; METASTASIS; PALLIATIVE THERAPY; PARTIAL NEPHRECTOMY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; TUMOR THROMBUS; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CARCINOMA, RENAL CELL; FEMALE; FIBROBLAST GROWTH FACTOR 2; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; RENAL VEINS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; VENA CAVA, INFERIOR;

EID: 0034778549     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(01)00290-8     Document Type: Article

References (32)

1. Angiogenesis
2. Fibroblast growth factor-2
3. Elevated levels of basic fibroblast growth factor in patients with limb ischemia
4. Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers
5. Fibroblast growth factors: An epigenetic mechanism of broad spectrum resistance to anticancer drugs
6. The implications of angiogenesis for the biology and therapy of cancer metastasis
7. Prognostic significance of microvessel count in low stage renal cell carcinoma
8. Microvessel density in renal cell carcinoma: Lack of prognostic significance
9. Characterization of a heparin-binding growth factor from adenocarcinoma of the kidney
10. Gene expression and immunohistochemical localization of basic fibroblast growth factor in renal cell carcinoma
11. Expression of basic fibroblast growth factor in primary human renal tumors: Correlation with poor survival
12. Basic fibroblast growth factor (FGF-2) in renal cell carcinoma, which is indistinguishable from that in normal kidney, is involved in renal cell carcinoma growth
13. Organ site-dependent expression of basic fibroblast growth factor in human renal cell carcinoma cells
14. Basic fibroblast growth factor secreted by an animal tumor is detectable in urine
15. Increased levels of fibroblast growth factor-like activity in urine from patients with bladder or kidney cancer
16. Increased serum levels of basic fibroblast growth factor in patients with renal cell carcinoma
17. Basic fibroblast growth factor as a candidate tumor marker for renal cell carcinoma
18. Improved enzyme immunoassay for human basic fibroblast growth factor using a new enhanced chemiluminescence system
19. Increased serum levels of basic fibroblast growth factor (bFGF) are associated with progressive lung metastases in advanced renal cell carcinoma patients
20. Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma?
21. Cytokine levels in cystic renal masses associated with renal cell carcinoma
22. Serum concentrations of VEGF and b-FGF in renal cell, prostate and urinary bladder carcinomas
23. Renal cell carcinoma: Relevance of angiogenic factors
24. Diagnosis and management of renal cell carcinoma. A clinical and pathologic study of 309 cases
25. Hypoxia-mediated induction of acidic/basic fibroblast growth factor and platelet-derived growth factor in mononuclear phagocytes stimulates growth of hypoxic endothelial cells
26. Basic fibroblast growth factor as a biochemical marker of exercise-induced ischemia
27. Heparin protects basic and acidic FGF from inactivation
28. The stability of bFGF against thermal denaturation
29. Interferons α and β down-regulate the expression of basic fibroblast growth factor in human carcinomas
30. Interferon-α-mediated down-regulation of angiogenesis-related genes and therapy of bladder cancer are dependent on optimization of biological dose and schedule
31. Serum basic fibroblast growth factor and vascular endothelial growth factor in metastatic renal cell carcinoma treated with interferon alfa-2b